Toll Free : + 1-888-961-4454 | Int'l : + 91 (788) 802-9103 | support@researchdive.com
LI22128592 |
Pages: 250 |
Dec 2022 |
Moist wound dressings are the most commonly used dressings in wound care. The rising popularity of moist wound dressings can be attributed to factors such as optimal moisture levels for cell growth and proliferation and expansion during wound healing phases. Moist wound dressings have advantages over standard dressings, such as proper exudate control, less pain and scarring, and faster wound healing.
A moist wound environment has several advantages that lead to faster and higher-quality healing. It promotes and facilitates keratinocyte migration over the wound surface, reduces pain and scarring, activates collagen synthesis, and supports the presence and function of nutrients, growth factors, and other soluble mediators in the wound microenvironment. Wound dressings can be used to create, maintain, and control a moist healing environment. Films, foams, hydrocolloids, hydrogels, and alginates are the various types of moist wound dressings. These factors are anticipated to boost the moist wound dressings market growth.
Some of the disadvantages of moist wound dressings include air exposure. Exposure to air reduces the surface temperature of the wound, causing peripheral vasoconstriction, which reduces blood flow (carrying oxygen and nutrients) to the wound and delays healing. This factor restrains the growth of the moist wound dressings industry.
Growing demographics and economies in developing countries like China, Japan, and India are expected to drive growth in the Asia-Pacific moist wound dressings market. Furthermore, new innovations in wound care products and technologies, increased technology adoption, and increased patient awareness about infections are expected to open up new opportunities for the global moist wound dressings market.
On the basis of region, the North America moist wound dressing market accounted for the highest market share for moist wound dressings because of highly trained professionals, an increase in chronic disease incidence, and increase in awareness of moist wound dressing market trends and technologies in the region.
A wound dressing is a technique or procedure that protects the wound from microbial infections, necrosis spread, and new contamination. Wound dressing improves wound healing by covering them with a moist wound healing bandage. Wounds are caused by damage to living tissue as a result of burns, accidents, cuts, scrapes, and chronic diseases such as diabetes.
Moist wound dressing creates a moist environment that aids in wound healing. This moist wound environment protects tissues from dehydration, alleviates pain, and promotes the breakdown of dead tissue.
The COVID-19 pandemic had a significant impact on healthcare systems' ability to provide curative and preventive services, particularly to the most vulnerable populations. During the pandemic, wound treatment centers in Italy saw a significant decrease in the number of hospital admissions because only emergencies, such as severe infections or wound hemorrhagic complications, were permitted in the hospitals.
The COVID-19 pandemic impacted primary-care clinician consultations, hospitalizations, and diagnostic workups for moist wound care management. The pandemic's restrictions had no negative impact on wound-related QOL or home care. Many healthcare organizations and governments used telemedicine for wound care management, particularly in cases of severe wounds, because it reduced the risk of infection and contact between physicians and patients. However, telemedicine had a negligible impact on wound care management in Germany despite its obvious benefits in risk reduction.
Moist wound dressings have vast application in healthcare for hospitalized patients. The increase in chronic wound conditions in developing countries is one of the factors that drive the moist wound market growth. According to the American Burn Association, about 450,000 patients are admitted each year in the U.S. as a result of burns, increasing their risk of infection. According to a survey conducted by the Centers for Disease Control and Prevention (CDC) in January 2020, surgical site infection (SSI) is one of the most expensive types of healthcare-associated illness (HAI) in the U.S. As a result, the market for moist wound dressings is rising at a quicker rate.
To know more about global moist wound dressings market drivers, get in touch with our analysts here.
The global wound dressings market is expected to be impacted by challenges such as product recalls, the availability of alternative products, and the high cost of wound dressing products during the forecast period. A growing number of product recalls are caused by product malfunction, component inconsistency, and packaging issues. However, the cost of care with advanced wound dressings is frequently high when compared to traditional wound dressings, which is anticipated to hamper the moist wound dressings market growth.
Numerous advancements in wound dressing contribute significantly to the market's overall growth. Wound dressing advancements have resulted in a shift from basic dressings to advanced pharmaceutically active ingredient products and devices. Wound dressings have advanced to the point where, while actively encouraging wound healing, they now maintain a moist wound environment. Furthermore, new treatments such as radiation therapy, electrical stimulation, nanotechnology, and the use of silver and other hybrid bandages are being introduced to improve the overall industry. These advancements provide patients with great relief during any trauma recovery, thereby increasing demand and serving as high-impact rendering drivers for the overall market.
To know more about global moist wound dressings market opportunities, get in touch with our analysts here.
On the basis of product, the moist wound dressings market outlook is divided into foam dressings, hydrocolloid dressings, film dressings, alginate dressings, hydrogel dressings, and other dressings. Among these, the foam dressings segment accounted for the highest market share in 2021, whereas the hydrogel dressings segment is estimated to show the fastest growth during the forecast period.
Source: Research Dive Analysis
The foam dressings segment accounted for a dominant moist wound dressings market share in 2021. Foam dressings are partially permeable polyurethane wound dressings. They are non-linting and non-adherent dressings that only enable water vapor to enter and prevent germs and other pollutants from entering. Foam dressings can be used to treat surgical wounds, skin grafts, mild burns, skin irritation, infected wounds, facial injuries, draining mucous membrane wounds, and leg ulcers.
The hydrogel dressings segment is anticipated to show the fastest growth during the forecast period. The hydrogel dressing can control wound infection and perform autolytic debridement of necrotic tissue by piggybacking on antibiotics or anti-inflammatory drugs during the inflammatory phase. Hydrogel dressings provide moisture and are suitable for wounds of any size, full or partial thickness. They can also be used in necrotic or infected wounds. Hydrogel dressings are made up of 90% water in a gel suspension.
On the basis of application, the market has been divided into diabetic foot ulcers, pressure ulcers, venous leg ulcers, surgical and traumatic wounds, burns, and others. Among these, the surgical and traumatic wounds segment accounted for the highest revenue share in 2021.
Source: Research Dive Analysis
The surgical and traumatic wounds segment accounted for the highest moist wound dressings market share in 2021. A traumatic wound is an unexpected, unplanned injury that can range from minor to severe, such as a gunshot wound. Abrasions, lacerations, skin tears, bites, burns, and penetrating trauma wounds are examples of traumatic wounds. Surgical wounds are formed when a surgeon makes an incision or cut with a scalpel, a surgical instrument. A wide range of medical conditions surgery. The size of a wound is determined by the procedure and location on the body.
On the basis of end use, the market is divided into hospitals, clinics, and home healthcare. Among these, the hospitals segment accounted for the highest revenue share in 2021.
Source: Research Dive Analysis
The hospitals segment accounted for the highest market share in 2021. The hospitals segment is driven by the rise in prevalence of chronic diseases and wounds. Furthermore, the increase in prevalence of hospital-acquired illnesses is expected to boost the segment. The rise in use of technologically improved wound care products will drive this segment's growth during the forecast period.
The moist wound dressings market was investigated across North America, Europe, Asia-Pacific, and LAMEA.
Source: Research Dive Analysis
North America is expected to dominate the overall moist wound dressings market during the forecast period. The dominance is due to the rise in the prevalence of diabetes, burns, and surgeries, which has led to an increase in the cases of surgical site infection (SSI) in the U.S., necessitating effective management of these wounds. For example, according to a survey report published in January 2020 by the Centers for Disease Control and Prevention, SSI is the most expensive healthcare-associated infection (HAI) type in the U.S., accounting for an estimated annual cost of about $3.3 billion and affecting more than 1 million additional inpatient-days annually, which is expected to drive product demand in the near future.
Product launches and mergers & acquisitions are common strategies followed by major market players. For instance, in March 2020, Advanced Medical Solutions Group plc acquired Raleigh Adhesion Coatings Ltd., an independent wound care and bio-diagnostics coatings company. This acquisition expanded the company's product line and strengthened its market position.
Source: Research Dive Analysis
Some of the leading moist wound dressings market players are Coloplast A/S, 3M, Cardinal Health, Inc., Medline Industries, Inc., Smith & Nephew plc, B. Braun, Convatec Group plc, Systagenix Wound Management Ltd., Derma Sciences, and Hollister Incorporated.
| Aspect | Particulars |
| Historical Market Estimations | 2020 |
| Base Year for Market Estimation | 2021 |
| Forecast Timeline for Market Projection | 2022-2031 |
| Geographical Scope | North America, Europe, Asia-Pacific, and LAMEA |
| Segmentation by Product |
|
| Segmentation by Application |
|
| Segmentation by End Use |
|
| Key Companies Profiled |
|
1.Research Methodology
1.1.Desk Research
1.2.Real time insights and validation
1.3.Forecast model
1.4.Assumptions and forecast parameters
1.5.Market size estimation
1.5.1.Top-down approach
1.5.2.Bottom-up approach
2.Report Scope
2.1.Market definition
2.2.Key objectives of the study
2.3.Report overview
2.4.Market segmentation
2.5.Overview of the impact of COVID-19 on Global moist wound dressings market
3.Executive Summary
4.Market Overview
4.1.Introduction
4.2.Growth impact forces
4.2.1.Drivers
4.2.2.Restraints
4.2.3.Opportunities
4.3.Market value chain analysis
4.3.1.List of raw material suppliers
4.3.2.List of manufacturers
4.3.3.List of distributors
4.4.Innovation & sustainability matrices
4.4.1.Application matrix
4.4.2.Regulatory matrix
4.5.Porter’s five forces analysis
4.5.1.Bargaining power of suppliers
4.5.2.Bargaining power of consumers
4.5.3.Threat of substitutes
4.5.4.Threat of new entrants
4.5.5.Competitive rivalry intensity
4.6.PESTLE analysis
4.6.1.Political
4.6.2.Economical
4.6.3.Social
4.6.4.Technological
4.6.5.Environmental
4.7.Impact of COVID-19 on Moist Wound Dressings market
4.7.1.Pre-covid market scenario
4.7.2.Post-covid market scenario
5.Moist Wound Dressings Market Analysis, by Product
5.1.Overview
5.2.Foam Dressings
5.2.1.Definition, key trends, growth factors, and opportunities
5.2.2.Market size analysis, by region, 2022-2031
5.2.3.Market share analysis, by country, 2022-2031
5.3.Hydrocolloid Dressings
5.3.1.Definition, key trends, growth factors, and opportunities
5.3.2.Market size analysis, by region, 2022-2031
5.3.3.Market share analysis, by country, 2022-2031
5.4.Film Dressings
5.4.1.Definition, key trends, growth factors, and opportunities
5.4.2.Market size analysis, by region, 2022-2031
5.4.3.Market share analysis, by country, 2022-2031
5.5.Alginate Dressings
5.5.1.Definition, key trends, growth factors, and opportunities
5.5.2.Market size analysis, by region, 2022-2031
5.5.3.Market share analysis, by country, 2022-2031
5.6.Hydrogel Dressings
5.6.1.Definition, key trends, growth factors, and opportunities
5.6.2.Market size analysis, by region, 2022-2031
5.6.3.Market share analysis, by country, 2022-2031
5.7.Other Dressings
5.7.1.Definition, key trends, growth factors, and opportunities
5.7.2.Market size analysis, by region, 2022-2031
5.7.3.Market share analysis, by country, 2022-2031
5.8.Research Dive Exclusive Insights
5.8.1.Market attractiveness
5.8.2.Competition heatmap
6.Moist Wound Dressings Market Analysis, by Application
6.1.Overview
6.2.Diabetic Foot Ulcers
6.2.1.Definition, key trends, growth factors, and opportunities
6.2.2.Market size analysis, by region, 2022-2031
6.2.3.Market share analysis, by country, 2022-2031
6.3.Pressure Ulcers
6.3.1.Definition, key trends, growth factors, and opportunities
6.3.2.Market size analysis, by region, 2022-2031
6.3.3.Market share analysis, by country, 2022-2031
6.4.Venous Leg Ulcers
6.4.1.Definition, key trends, growth factors, and opportunities
6.4.2.Market size analysis, by region, 2022-2031
6.4.3.Market share analysis, by country, 2022-2031
6.5.Surgical and Traumatic Wounds
6.5.1.Definition, key trends, growth factors, and opportunities
6.5.2.Market size analysis, by region, 2022-2031
6.5.3.Market share analysis, by country, 2022-2031
6.6.Burns
6.6.1.Definition, key trends, growth factors, and opportunities
6.6.2.Market size analysis, by region, 2022-2031
6.6.3.Market share analysis, by country, 2022-2031
6.7.Others
6.7.1.Definition, key trends, growth factors, and opportunities
6.7.2.Market size analysis, by region, 2022-2031
6.7.3.Market share analysis, by country, 2022-2031
6.8.Research Dive Exclusive Insights
6.8.1.Market attractiveness
6.8.2.Competition heatmap
7. Moist Wound Dressings Market Analysis, by End-Use
7.1.Overview
7.2.Hospitals
7.2.1.Definition, key trends, growth factors, and opportunities
7.2.2.Market size analysis, by region, 2022-2031
7.2.3.Market share analysis, by country, 2022-2031
7.3.Clinics
7.3.1.Definition, key trends, growth factors, and opportunities
7.3.2.Market size analysis, by region, 2022-2031
7.3.3.Market share analysis, by country, 2022-2031
7.4.Home Healthcare
7.4.1.Definition, key trends, growth factors, and opportunities
7.4.2.Market size analysis, by region, 2022-2031
7.4.3.Market share analysis, by country, 2022-2031
7.5.Research Dive Exclusive Insights
7.5.1.Market attractiveness
7.5.2.Competition heatmap
8.Moist Wound Dressings Market, by Region
8.1.North America
8.1.1.U.S.
8.1.1.1.Market size analysis, by Product, 2022-2031
8.1.1.2.Market size analysis, by Application, 2022-2031
8.1.1.3.Market size analysis, by End use, 2022-2031
8.1.2.Canada
8.1.2.1.Market size analysis, by Product, 2022-2031
8.1.2.2.Market size analysis, by Application, 2022-2031
8.1.2.3.Market size analysis, by End use, 2022-2031
8.1.3.Mexico
8.1.3.1.Market size analysis, by Product, 2022-2031
8.1.3.2.Market size analysis, by Application, 2022-2031
8.1.3.3.Market size analysis, by End use, 2022-2031
8.1.4.Research Dive Exclusive Insights
8.1.4.1.Market attractiveness
8.1.4.2.Competition heatmap
8.2.Europe
8.2.1.Germany
8.2.1.1.Market size analysis, by Product, 2022-2031
8.2.1.2.Market size analysis, by Application, 2022-2031
8.2.1.3.Market size analysis, by End use, 2022-2031
8.2.2.UK
8.2.2.1.Market size analysis, by Product, 2022-2031
8.2.2.2.Market size analysis, by Application, 2022-2031
8.2.2.3.Market size analysis, by End use, 2022-2031
8.2.3.France
8.2.3.1.Market size analysis, by Product, 2022-2031
8.2.3.2.Market size analysis, by Application, 2022-2031
8.2.3.3.Market size analysis, by End use, 2022-2031
8.2.4.Spain
8.2.4.1.Market size analysis, by Product, 2022-2031
8.2.4.2.Market size analysis, by Application, 2022-2031
8.2.4.3.Market size analysis, by End use, 2022-2031
8.2.5.Italy
8.2.5.1.Market size analysis, by Product, 2022-2031
8.2.5.2.Market size analysis, by Application, 2022-2031
8.2.5.3.Market size analysis, by End use, 2022-2031
8.2.6.Rest of Europe
8.2.6.1.Market size analysis, by Product, 2022-2031
8.2.6.2.Market size analysis, by Application, 2022-2031
8.2.6.3.Market size analysis, by End use, 2022-2031
8.2.7.Research Dive Exclusive Insights
8.2.7.1.Market attractiveness
8.2.7.2.Competition heatmap
8.3.Asia-Pacific
8.3.1.China
8.3.1.1.Market size analysis, by Product, 2022-2031
8.3.1.2.Market size analysis, by Application, 2022-2031
8.3.1.3.Market size analysis, by End use, 2022-2031
8.3.2.Japan
8.3.2.1.Market size analysis, by Product, 2022-2031
8.3.2.2.Market size analysis, by Application, 2022-2031
8.3.2.3.Market size analysis, by End use, 2022-2031
8.3.3.India
8.3.3.1.Market size analysis, by Product, 2022-2031
8.3.3.2.Market size analysis, by Application, 2022-2031
8.3.3.3.Market size analysis, by End use, 2022-2031
8.3.4.Australia
8.3.4.1.Market size analysis, by Product, 2022-2031
8.3.4.2.Market size analysis, by Application, 2022-2031
8.3.4.3.Market size analysis, by End use, 2022-2031
8.3.5.South Korea
8.3.5.1.Market size analysis, by Product, 2022-2031
8.3.5.2.Market size analysis, by Application, 2022-2031
8.3.5.3.Market size analysis, by End use, 2022-2031
8.3.6.Rest of Asia-Pacific
8.3.6.1.Market size analysis, by Product, 2022-2031
8.3.6.2.Market size analysis, by Application, 2022-2031
8.3.6.3.Market size analysis, by End use, 2022-2031
8.3.7.Research Dive Exclusive Insights
8.3.7.1.Market attractiveness
8.3.7.2.Competition heatmap
8.4.LAMEA
8.4.1.Brazil
8.4.1.1.Market size analysis, by Product, 2022-2031
8.4.1.2.Market size analysis, by Application, 2022-2031
8.4.1.3.Market size analysis, by End use, 2022-2031
8.4.2.Saudi Arabia
8.4.2.1.Market size analysis, by Product, 2022-2031
8.4.2.2.Market size analysis, by Application, 2022-2031
8.4.2.3.Market size analysis, by End use, 2022-2031
8.4.3.UAE
8.4.3.1.Market size analysis, by Product, 2022-2031
8.4.3.2.Market size analysis, by Application, 2022-2031
8.4.3.3.Market size analysis, by End use, 2022-2031
8.4.4.South Africa
8.4.4.1.Market size analysis, by Product, 2022-2031
8.4.4.2.Market size analysis, by Application, 2022-2031
8.4.4.3.Market size analysis, by End use, 2022-2031
8.4.5.Rest of LAMEA
8.4.5.1.Market size analysis, by Product, 2022-2031
8.4.5.2.Market size analysis, by Application, 2022-2031
8.4.5.3.Market size analysis, by End use, 2022-2031
8.4.6.Research Dive Exclusive Insights
8.4.6.1.Market attractiveness
8.4.6.2.Competition heatmap
9.Competitive Landscape
9.1.Top winning strategies, 2022
9.1.1.By strategy
9.1.2.By year
9.2.Strategic overview
9.3.Market share analysis, 2022
10.Company Profiles
10.1.Coloplast A/S
10.1.1.Overview
10.1.2.Business segments
10.1.3.Product portfolio
10.1.4.Financial performance
10.1.5.Recent developments
10.1.6.SWOT analysis
10.1.7.Research Dive Analyst View
10.2. 3M Healthcare
10.2.1.Overview
10.2.2.Business segments
10.2.3.Product portfolio
10.2.4.Financial performance
10.2.5.Recent developments
10.2.6.SWOT analysis
10.2.7.Research Dive Analyst View
10.3.Cardinal Health, Inc.
10.3.1.Overview
10.3.2.Business segments
10.3.3.Product portfolio
10.3.4.Financial performance
10.3.5.Recent developments
10.3.6.SWOT analysis
10.3.7.Research Dive Analyst View
10.4. Medline Industries, Inc.
10.4.1.Overview
10.4.2.Business segments
10.4.3.Product portfolio
10.4.4.Financial performance
10.4.5.Recent developments
10.4.6.SWOT analysis
10.4.7.Research Dive Analyst View
10.5.Smith & Nephew PLC
10.5.1.Overview
10.5.2.Business segments
10.5.3.Product portfolio
10.5.4.Financial performance
10.5.5.Recent developments
10.5.6.SWOT analysis
10.5.7.Research Dive Analyst View
10.6.B. Braun Melsungen AG
10.6.1.Overview
10.6.2.Business segments
10.6.3.Product portfolio
10.6.4.Financial performance
10.6.5.Recent developments
10.6.6.SWOT analysis
10.6.7.Research Dive Analyst View
10.7.ConvaTec Group PLC
10.7.1.Overview
10.7.2.Business segments
10.7.3.Product portfolio
10.7.4.Financial performance
10.7.5.Recent developments
10.7.6.SWOT analysis
10.7.7.Research Dive Analyst View
10.8.Systagenix Wound Management Ltd.
10.8.1.Overview
10.8.2.Business segments
10.8.3.Product portfolio
10.8.4.Financial performance
10.8.5.Recent developments
10.8.6.SWOT analysis
10.8.7.Research Dive Analyst View
10.9.Derma Sciences, Inc.
10.9.1.Overview
10.9.2.Business segments
10.9.3.Product portfolio
10.9.4.Financial performance
10.9.5.Recent developments
10.9.6.SWOT analysis
10.9.7.Research Dive Analyst View
10.10.Hollister Incorporated
10.10.1.Overview
10.10.2.Business segments
10.10.3.Product portfolio
10.10.4.Financial performance
10.10.5.Recent developments
10.10.6.SWOT analysis
10.10.7.Research Dive Analyst View
11.Appendix
11.1.Parent & peer market analysis
11.2.Premium insights from industry experts
11.3.Related reports
* Taxes/Fees, If applicable will be added during checkout. All prices in USD.
Have a question ?
Enquire To BuyNeed to add more ?
Request Customization
